|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Corley DA and Buffler PA: Oesophageal and
gastric cardia adenocarcinomas: analysis of regional variation
using the Cancer Incidence in Five Continents database. Int J
Epidemiol. 30:1415–1425. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hiyama T, Tanaka S, Shima H, Kose K,
Kitadai Y, Ito M, Sumii M, Yoshihara M, Shimamoto F, Haruma K and
Chayama K: Somatic mutation of mitochondrial DNA in Helicobacter
pylori-associated chronic gastritis in patients with and
without gastric cancer. Int J Mol Med. 12:169–174. 2003.PubMed/NCBI
|
|
5
|
Diehl JA: Cycling to cancer with cyclin
D1. Cancer Biol Ther. 1:226–231. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Biliran H Jr, Wang Y, Banerjee S, Xu H,
Heng H, Thakur A, Bollig A, Sarkar FH and Liao JD: Overexpression
of cyclin D1 promotes tumor cell growth and confers resistance to
cisplatin-mediated apoptosis in an elastase-myc
transgene-expressing pancreatic tumor cell line. Clin Cancer Res.
11:6075–6086. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hall M and Peters G: Genetic alterations
of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human
cancer. Adv Cancer Res. 68:67–108. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Knudsen KE, Diehl JA, Haiman CA and
Knudsen ES: Cyclin D1: polymorphism, aberrant splicing and cancer
risk. Oncogene. 25:1620–1628. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bagos PG and Nikolopoulos GK: A method for
meta-analysis of case-control genetic association studies using
logistic regression. Stat Appl Genet Mol Biol. 6:Article17.
2007.PubMed/NCBI
|
|
12
|
Li H, Ha TC and Tai BC: XRCC1 gene
polymorphisms and breast cancer risk in different populations: a
meta-analysis. Breast. 18:183–191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu C, Lu W, Tan W, Xing D, Liang G, Miao X
and Lin D: Lack of association between CCND1 G870A polymorphism and
risk of esophageal squamous cell carcinoma. Cancer Epidemiol
Biomarkers Prev. 12:1762003.PubMed/NCBI
|
|
14
|
Zhang J, Li Y, Wang R, Wen D, Sarbia M,
Kuang G, Wu M, Wei L, He M, Zhang L and Wang S: Association of
cyclin D1 (G870A) polymorphism with susceptibility to esophageal
and gastric cardiac carcinoma in a northern Chinese population. Int
J Cancer. 105:281–284. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Casson AG, Zheng Z, Evans SC, Geldenhuys
L, van Zanten SV, Veugelers PJ, Porter GA and Guernsey DL: Cyclin
D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
Cancer. 104:730–739. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Geddert H, Kiel S, Zotz RB, Zhang J,
Willers R, Gabbert HE and Sarbia M: Polymorphism of p16 INK4A and
cyclin D1 in adenocarcinomas of the upper gastrointestinal tract. J
Cancer Res Clin Oncol. 131:803–808. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jain M, Kumar S, Lal P, Tiwari A, Ghoshal
UC and Mittal B: Role of BCL2 (ala43thr), CCND1 (G870A) and FAS
(A-670G) polymorphisms in modulating the risk of developing
esophageal cancer. Cancer Detect Prev. 31:225–232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu G, Cescon DW, Zhai R, Zhou W, Kulke
MH, Ma C, Xu W, Su L, Asomaning K, Heist RS, et al: p53 Arg72Pro,
MDM2 T309G and CCND1 G870A polymorphisms are not associated with
susceptibility to esophageal adenocarcinoma. Dis Esophagus.
23:36–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hussain S, M Y, Thakur N, Salam I, Singh
N, Mir MM, Bhat MA, Siddiqi MA, Das BC and Bharadwaj M: Association
of cyclin D1 gene polymorphisms with risk of esophageal squamous
cell carcinoma in Kashmir Valley: a high risk area. Mol Carcinog.
50:487–498. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen B, Cao L, Yang P, Zhou Y and Wu XT:
Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent
risk factor for digestive tract cancers: a meta-analysis comprising
20,271 subjects. Cancer Epidemiol. 36:106–115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Higgins JP: Commentary: heterogeneity in
meta-analysis should be expected and appropriately quantified. Int
J Epidemiol. 37:1158–1160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Groenwold RH, Rovers MM, Lubsen J and van
der Heijden GJ: Subgroup effects despite homogeneous heterogeneity
test results. BMC Med Res Methodol. 10:432010. View Article : Google Scholar : PubMed/NCBI
|
